first call review, no answer
client transferred form Borders Aesthetics, doing well on medication, no side effects, managing to maintain same weight for a while now
current BMI 22, happy to continue on Mounjaro 7.5mg
The client's medical history was reviewed in full, and no contraindications to treatment were identified.
The client is currently taking hormone replacement therapy (HRT) and cholecalciferol. Their current weight is 71 kg, height is 1.60 m, and BMI is 27.7 kg/m². Waist circumference measures 96 cm, indicating central obesity.
The client reports struggling to lose weight since the onset of menopause despite lifestyle measures. They expressed a desire to lose approximately 6–9 kg to improve their overall health and wellbeing. Based on the clinical assessment, the client is considered suitable for prescription weight management treatment.
The available prescription treatment options were discussed in detail, including their benefits, risks, expected outcomes, and potential side effects. Following an informed discussion, the client elected to commence treatment with Wegovy (semaglutide) injections.
The common and serious potential side effects of Wegovy were explained, and the client demonstrated understanding. Comprehensive counselling was provided on the correct use of the Wegovy pen, including administration technique, dose schedule, storage, and disposal of needles.
A prescription for Wegovy 0.25 mg pen was issued. A follow-up telephone review has been booked to assess tolerability, adherence, and treatment response. The client's GP has been notified of the treatment plan and prescription.
medical assessment completed but not booked zoom call yet, follow up call/message sent
client transferred form Borders Aesthetics, medical history reviewed no contraindications to treatment, started weight loss on 3/11/25 currently on Mounjaro 10mg, happy with current strength no side effects, had a few days off in the last 4 weeks and in that time gained 3Ibs but returned to normal routine after holidays and overall lost 1.8kg, increased physical activity with long walks 2-3times per week
starting weight 125.3kg
current weight 98.4kg (-1.8kg in 4 weeks and -26.9kg since start)
starting BMI 43 current one 33
submitted updated weight
client transferring form Borders Aesthetics, on weight loss treatment since 14/02/2024 with two breaks due to unrelated health problems, struggling with this titration, not noticing appetite reduction and that reflects in weight loss, although not gain any weight, not lost any as well. currently on Mounjaro 7.5mg, next pen dose increase to 10mg, prescription issued
client transferring form borders aesthetics, currently on Mounjaro 12.5mg, happy to stay on the same strength as it working well,
starting weight 131.4 kg (started on December 2024) (-41.6kg since start), no side effects and no changes in medical history
follow up call with client, no changes in medical history, managing well on medication appetite reduced although in the first few weeks had times when was more hungry, slight nausea and diahhorea both manageable, advice given on management, managing doing injections ok, next pen dose increase Mounjaro 5mg, prescription issued
starting weight 84kg (-3kg since start 3 weeks)
no answer, call rescheduled
doing well on medication, appetite reduced and weight is coming off, although noticed in the first few weeks appetite being up and down that's seems to settle, slight nausea occasionally, manageable, next pen dose increase Mounjaro 5mg prescription issued
starting weight 97kg
current weight 94.6kg (-2.4kg in the last three weeks)
client BMI calculated and with BMI 24 not suitable for treatment, explained treatment guidance
The client attended for an initial consultation to commence Mounjaro (tirzepatide) injections for weight management. The client has no known medical conditions and no known allergies. They confirmed they are not pregnant and are not breastfeeding. The client uses an intrauterine contraceptive coil for contraception. Identity was checked and verified prior to treatment.
Baseline measurements were recorded. Current weight is 73.6 kg, waist circumference is 100 cm, and BMI is 28.75 kg/m². Central adiposity was noted on assessment. The client's target weight loss is 6–10 kg.
The client was assessed as suitable to commence Mounjaro treatment. The risks, benefits, potential side effects, expected treatment outcomes, and the importance of maintaining a healthy diet and regular physical activity alongside treatment were discussed. The client demonstrated understanding of the information provided, had the opportunity to ask questions, and gave informed consent to proceed with treatment.
client transfer from Borders Aesthetics
medical questionnaire reviews client BMI 27 with waist circumference 86cm, central adiposity, suitable for treatment
left message
starting weight 136kg
weight 4 weeks ago 100.1kg
client moving to online pharmacy from Borders Aesthetics, doing well on medication, no side effects, currently in healthy BMI maintaining current weight
starting weight 83.3kg current weight 57.15 (-26.15kg since start and -1kg in the last 4 weeks)
post medication together with sons.
happy to stay on current dose, no changes in medical history
prescription for Mounjaro 2.5mg pen issued
doing well on medication, no side effects, appetite reduced, happy to continue on the same strength, Rx for Mounjaro1 0mg pen issued, no changes in medical history
starting weight 136kg
current weight 90kg own scale(-46kg since start and -10kg in the last 4 weeks)
left message
doing well on medication, no side effects apart form slight nausea after evening meal, advice given on overeating, appetite reduced and notice difference but fells sometimes hungry, follow up call booked, notification of start of the treatment sent to Dr Stewart Coldstream medical Practice
doing well on medication, no side effects, appetite reduced, although occasionally still feels hungry, managing injections well with daughter help, follow up call booked
client transferred for Bordered Aesthetics, initial starting weight 75.5kg BMI 30.5, current weight 66kg, medical history reviewed no contraindications to treatment, currently on Wegovy 1mg and that seems to be working well when comes to reducing appetite and maintaining weight. no side effects, prescription for 1mg Wegovy issued
Client phone as suffering diahorea in the last few days, She went away on holidays and that's went started, (Friday) settle by Monday but Tuesday was a an injection day and symptoms returned, advice given on managing symptoms including electrolites and loperamide, client is going on holidays when next dose is due, agreed to missed that dose and restart after the holidays
client BMI 27 with waist circumference 82cm (central adiposity) suitable for treatment